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Bollgard® III was developed by combining cotton events COT102 and MON 15985 through conventional
breeding to improve efﬁcacy against lepidopteran feeding damage. COT102 produces the Vip3Aa19
protein and MON 15985 produces the Cry1Ac and Cry2Ab2 proteins. COT102 MON 15985 has also been
bred with Roundup Ready Flex® cotton (MON 88913) that confers glyphosate tolerance. This study
evaluated the activity of COT102 and MON 15985 and the combined activity of COT102 and MON 15985
against the cotton bollworm (CBW, Helicoverpa zea). COT102, MON 15985, COT102  MON 15985 and
COT102  MON 15985  MON 88913 have comparable Vip3Aa19 and/or Cry1Ac, Cry2Ab2 protein
expression levels as determined by enzyme-linked immunosorbent assay. CBW demonstrated
concentration-dependent growth inhibition after 7-days of feeding on lyophilized leaf tissue derived
from COT102, MON 15985, COT102 MON 15985 and COT102 MON 15985 MON 88913 incorporated
into an artiﬁcial diet. Observed EC50 values for COT102 MON 15985 and COT102 MON 15985 MON
88913 were comparable (4% deviation) with the predicted EC50 value under the assumption of addi-
tivity using the combined activity of COT102 and MON 15985. No interaction in biological activity be-
tween COT102 and MON 15985 is consistent with results from competition and ligand blotting assays
that demonstrated that Vip3Aa does not inhibit the binding of either Cry1Ac or Cry2Ab2 and vice versa.
The results from this study demonstrate that the activity of COT102  MON 15985 against CBW is
consistent with predictions of additivity.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Genetically engineered (GE) crops producing plant incorporated
protectants (PIPs) for control of economically important pests have
been commercially cultivated for over two decades. To improve the
efﬁcacy, pest spectrum, and durability of these products, individual
products containing these PIPs have been combined through con-
ventional breeding to produce combined trait (i.e., stacked) prod-
uct. To realize these improvements with a stacked product, the
approach has been to combine PIPs with similar target spectra that
have been shown to act independently and do not exhibit cross-
resistance (Greenplate et al., 2003; U.S. EPA, 2005; U.S. EPA,
2008). Recently, Carriere et al. (2015) has pointed out that cross-es, Monsanto Company, St.
L. Levine).
Inc. This is an open access article uresistance is less likely between toxins that differ have unique
binding properties and lack sequence and structural homology.
Presently, GE crops with combined insecticidal PIPs are commer-
cially available for cotton, corn and soybean (ISAAA, 2015).
Recently, Monsanto Company developed and registered Boll-
gard® III, which combines cotton event COT102 and Bollgard® II
(MON 15985) through conventional breeding and provides pro-
tection from feeding damage by several lepidopteran cotton pests
(e.g., cotton bollworm, (CBW), Helicoverpa zea) (U.S. EPA, 2014;
OGTR, 2014; CIBIOGEM, 2014). MON 15985 was produced by sta-
ble insertion of the coding sequence of the Cry2Ab2 protein from
Bacillus thuringiensis (Bt) subspecies kurstaki into the genome of
Bollgard® cotton variety DP50B. The original Bollgard cotton was
produced by the stable insertion of the coding sequence for CrylAc
protein from Bt subspecies kurstaki. The spectrum of activity for the
Cry1A and Cry2Ab2 proteins are speciﬁc for Lepidoptera and the
combined activity of the Cry1Ac and Cry2Ab2 proteins has previ-
ously been shown to be independent and additive (De Maagd et al.,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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was produced by stable insertion of the coding sequence for the
Vip3Aa19 insecticidal protein (hereafter Vip3Aa) isolated from
Bacillus thuringiensis (Bt) strain AB88 (U.S. EPA, 2008). There is no
sequence and structural similarity between Vip3Aa and with
known Bt d-endotoxins or other toxin genes (Estruch et al., 1996)
which made it a good candidate to combine with a Cry1A and
Cry2Ab2 toxins to minimize the likelihood of cross resistance.
However, the mode of action of Vip3Aa has some similarities to Cry
proteins by forming membrane channels however with different
biophysical properties (Estruch et al., 1996; Lee et al., 2003). Like
Cry1Ac and Cry2Ab2, Vip3Aa is lepidopteran active (Estruch et al.,
1996). COT102  MON 15985 has also been conventionally bred
with Roundup Ready Flex® cotton (MON 88913) to produce
COT102  MON 15985  MON 88913 that confers tolerance to
glyphosate by expressing the 5-enolpyruvyl-shikimate-3-
phosphate synthase protein (EPSPS) isolated from Agrobacterium
species strain CP4 (Padgette et al., 1995).
In 2009, the U.S. EPA codiﬁed a regulatory framework and data
requirements for assessing combined trait products producing PIPs
(U.S. EPA, 2009a; U.S. EPA, 2009b), which requires that three con-
ditions are satisﬁed to bridge back to the existing information for
the single products. The ﬁrst condition is conﬁrmation that the
presence and the structure of the inserted material have been
conserved in the stacked product. Conﬁrmation that the inserted
material in the parental lines has been conserved was shown by
Southern blot analysis for COT102  MON 15985 and
COT102  MON 15985  MON 88913 (OGTR, 2014). The second
requirement is to demonstrate comparable PIP expression in the
parental lines and the stack in representative plant tissues. Com-
parable expression in representative tissues indicates no mean-
ingful change in exposure with the stack product to humans and
non-target organisms (NTOs) that would impact the original
food/feed and environmental risk assessment for the single prod-
ucts. The stacked product COT102 MON 15985MON 88913 and
the single products COT102 and MON 15985 were show to have
comparable Cry1Ac, Cry2Ab2 and Vip3Aa expression levels (OGTR,
2014). Although not required for the U.S. EPA’s PIP bridging
assessment, CP4 EPSPS expression for glyphosate tolerance was
comparable in the stack and MON 88913 (OGTR, 2014). The third
requirement is evaluating for a potential synergistic interaction
between the PIPs using a target pest or another susceptible species.
An antagonism is not a safety concern and does not impact the
conclusions of the environmental assessment for stacked PIPs (U.S.
EPA, 2015). However, a synergism could potentially impact the
environmental risk assessment of stacked PIPs. If a synergy is
demonstrated, the level of the synergy is put into the context of the
environmental risk assessment and additional testing with a
mixture of the Bt proteins may not be required provided there are
adequatemargins of safety (EPA, 2009b). By demonstrating that the
PIPs act independently, along with adequate margins of safety for
each protein, allows for the proteins to be assessed independently.
This approach, for the safety assessment of the stacked product, is
based on a principle of independent assessment which has a long
standing application in the ﬁeld of toxicology and is inherent in
microbial risk assessments (U.S. EPA, 2004). In addition, if an
interaction is not observed with the largest stack of insecticidal
products (e.g., product A  product B  product C), it is then im-
plicit that no interaction will occur with sub-combinations (e.g.,
product A  product B, or product A  product C, product
B product C) (Koch et al., 2015). As an alternative to assessing for a
potential synergy between the PIPs, NTOs can be re-tested with all
of the PIPs in combination at levels that provide sufﬁcient margins
of exposure.
There are two well accepted models to assess additivity of twoor more substances, the concentration and the response addition
models (Finney, 1971; Bliss, 1939). Response addition has histori-
cally been used to assess binary endpoints for mixtures with
different modes of action (U.S. EPA, 1986; Green et al., 1995). Con-
centration addition is an established model for examining in-
teractions between substances having a similar mode of action such
as Bt proteins (U.S. EPA, 1986; Tabashnik, 1992; Olmstead and
LeBlanc, 2005). A mode of action is viewed as a category of
mechanisms that share particular key features or steps such as PIPs
derived from Bt proteins (U.S. EPA, 1986; Tabashnik, 1992). In
addition to assessing the potential for interaction, the experimental
design used to assess concentration addition is also well suited to
evaluate potency and efﬁcacy of two or more substances. Reliable
estimates of potency can be obtained by estimating 50% lethal or
effect concentrations (e.g., LC/EC50 values) and efﬁcacy can be
characterized with concentration effect relationships (Casarett
et al., 2003). Concentration addition usually generates slightly
more conservative predictions compared to response addition (i.e.,
higher predicted toxicity) and is suitable for either binary or
continuous data (de March 1987). However, predictions from both
models are very similar for compounds that have concentration-
response curves with logistic slopes that are approximately one
(de March 1987; Backhaus et al., 2010; Verbruggen, and van den
Brink, 2010). For these reasons, concentration addition is the U.S.
EPA’s preferred model for assessment of additivity (U.S. EPA, 1986;
Backhaus et al., 2010). However, both approaches have been used to
assess the combined activity of Bt proteins and to address regula-
tory requirements (U.S. EPA, 2008; U.S. EPA, 2009c).
The design of interaction studies has received considerable
attention in the scientiﬁc literature. Consequently, there have been
efforts to develop scientiﬁcally sound study designs which can vary
based on activity and speciﬁcity of the substances (Cassee et al.,
1998). A robust design for assessing potential interactions is the
ﬁxed-ratio or ray design (Cassee et al., 1998). With this design, the
concentration-response for each substance is characterized along
with the concentration-response for the combination at a ﬁxed
ratio. Fixed-ratio designs also provide a good visual interpretation
of the results even for combinations with many substances. Inter-
pretation of results using these methods are commonly based on
constructing a 95% conﬁdence interval (CI) around the ﬁtted effect
of the response and then analyzing whether the predicted effect is
captured by this conﬁdence interval (Tabashnik, 1992; Jonker et al.,
2011). The advantage of this design and approach is that it takes
into account the uncertainty in the prediction of the response
through the use of a 95% CI that is typically for the median effect
level. For combinations where one of the substances does not have
activity against the test organism because of taxonomic speciﬁcity,
characterizing concentration-response curves for one substance in
the presence and absence of a ﬁxed concentration of another
substance(s) is another acceptable approach (U.S. EPA, 2009c;
Raybould et al., 2011).
This study evaluated whether combining COT102 and MON
15985 through conventional breeding results in an interaction
between the Bt proteins expressed in stacked products. A hypoth-
esis of no interaction (additivity) was tested because the Bt proteins
expressed in the stacks have previously been shown to act inde-
pendently at the receptor binding level. No interaction among these
proteins is a supportable hypothesis based on existing studies.
Competition binding assays demonstrated that Vip3Aa does not
inhibit the binding of either Cry1Ac or Cry2Ab2 and vice versa (Lee
et al., 2006). In addition, it was shown by Lee et al. (2006), with
blotting experiments using brush border membrane vesicles from
CBW that Vip3Aa does not bind to the known Cry1Ac and Cry2Ab2
receptors. However, lack of high-afﬁnity binding does not preclude
interactions between toxins in general (Carriere et al., 2015) and
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2. Materials and methods
2.1. Experimental design
The biological activity of leaf tissue derived from COT102, MON
15985, COT102  MON 15985, and COT102  MON 15985  MON
88913 was characterized in diet-incorporation bioassays with the
cotton bollworm (CBW, Helicoverpa zea), which is sensitive to the
Vip3Aa, Cry1Ac and Cry2Ab2 proteins (Greenplate et al., 2003;
Raybould and Vlachos, 2011). Lyophilized leaf tissue was obtained
from plants at the 4 to 6 node growth stage. Growth inhibition was
selected as the response variable because it is a sensitive endpoint
that shows a large dynamic range and the CBW response is not
confounded over the concentration ranges tested in this study by
signiﬁcant increases in mortality. Diet exposure concentrations
followed a ﬁxed ratio or ray design. CBW was exposed to at least
ﬁve lyophilized leaf tissue diet-incorporation concentrations with
each test and control material assayed concurrently. Control tissue
was from a conventional cotton line with similar background ge-
netics to the singles and the stack and all events and prodcus and
the control were in the same variety. A Scientiﬁc Advisory Panel
convened by the U.S. EPA (2009b) that discussed the experimental
design for insect bioassay interaction studies for PIPs recom-
mended that each treatment should be replicated at least three
times on separate days to control for day-to-day variations in test
species physiology. Assays for each treatment were run concur-
rently (i.e., the singles and stacked events) and each treatment was
replicated three times on separate days each with a separate batch
of insects. Assays were scored after seven days which is a sufﬁcient
duration to assess concentration responses for CBW growth inhi-
bition. A summary of the test and control substances is provided in
Table 1. Estimated EC50 values for COT102 and MON 15985 were
used to predict the EC50 value for COT102  MON 15985 and
COT102  MON 15985  MON 88913 using the concentration
addition model (Finney, 1971; Tabashnik, 1992).
2.2. Tissue growth and preparation for CBW bioassays
Cotton plants were grown in a greenhouse under environmental
conditions suitable for the growth of cotton and irrigated as
needed. Each pot was thinned to one plant per pot at approximately
1e2 node growth stage. At the 1e2 node growth stage the most
recently emerged leaf from each plant was collected for identity
conﬁrmation and any plants where identity could not be conﬁrmed
were removed from the study. Leaf tissue was harvested at the 4e6
node stage (V4-V6) and pooled by entry. Leaf samples were then
placed in a VirTis® 24  48 GPFD Freeze Dryer (SP Industries, Stone
Ridge, NY). After one cycle (approximately two days), all tissue
samples were removed from the freeze dryer to obtain a baseline
dry weight in the container. This process was repeated until there
was no signiﬁcant difference in the tissue sample weights (>0.05 g)
when compared to the previous freeze drying cycle. All control andTable 1
Summary of treatments and Bacillus thuringiensis (Bt) proteins produced by COT102,
Treatment a Phenotype
Conventional control Conventional
COT102 Insect protected
MON 15985 Insect protected
COT102  MON 15985 Insect protected
COT102  MON 15985  MON 88913 Insect protected
a All test and control materials have similar genetic background.test tissue samples were assessed for moisture content with an IR-
200 Moisture Analyzer (Denver Instrument, Denver, CO) and all
tissues analyzed had a moisture content of less than 10%. Lyophi-
lized samples were pulverized into a ﬁne powder and the samples
were placed in a 80 C freezer until bioassay initiation.
2.3. Bioassay methodology
CBWgrowth inhibition by COT102, MON 15985, COT102 MON
15985, and COT102 MON15985 MON 88913 was characterized
in three replicate 7-day diet-incorporation bioassays. CBW eggs
were obtained from Benzon Research (Carlisle, PA). CBW eggs were
placed into covered boxes and held at a target temperature of 10 C
prior to being incubated for hatching at a target temperature of
27 C and 60% relative humidity. Three conventional control
treatments, each containing 1.5 mg of conventional control tissue/
mL of diet, were includedwith each of the three bioassay replicates.
Treatment concentrations were chosen to characterize
concentration-response relationships and to accurately estimate
EC50 values. For MON 15985, COT102  MON 15985 and
COT102  MON 15985  MON 88913 treatments, ﬁve diet con-
centrations were used ranging from 0.0090 to 0.141 mg tissue/mL
diet with a two-fold separation factor between concentrations. For
COT102 treatments, ﬁve diet concentrations were tested ranging
from 0.094 to 1.5 mg tissue/mL diet with a two-fold separation
factor between concentrations. Treatments had conventional con-
trol tissue added, when necessary, to obtain a ﬁnal tissue concen-
tration of 1.5 mg tissue/mL of diet, which equalized the amount of
leaf tissue in every treatment level. New dose preparations with
tissue were made for each replicated assay.
Treatments were prepared by mixing 5 mL of puriﬁed room
temperature water with or without ﬁnely-ground lyophilized leaf
tissue and then adding 20mL of warm (52± 4 C) agar-basedmulti-
species diet (Southland Products, Lake Village, AR). Diet was then
vortex-mixed until visually homogeneous. A volume of 1.0 mL of
diet was aliquoted into individual wells of 128-well bioassay trays
(Benzon Research, Carlisle, PA) and the diet was allowed to solidify.
One newly hatched CBW (<30 h from the ﬁrst observed hatching)
was placed in each well. Each treatment level contained 16 indi-
vidually housed CBW larvae and was covered with a ventilated
adhesive cover. At the end of the seven day incubation period, the
number of insects placed in each treatment level, the number of
surviving insects in each treatment level, and the combined insect
weight of the surviving insects in each treatment level was
recorded.
2.4. Concentration response modeling and assessment of additivity
Concentration response modeling and the median effect con-
centrations for growth inhibition (EC50) and their associated 95% CI
were estimated with a standard 3-parameter logistic equation (Van
Ewijk and Hoekstra, 1993). The EC50 value is deﬁned as the con-
centration that results in 50% growth inhibition relative to the
control and was selected as the endpoint because it is the mostMON 15985, COT102  MON 15985 and COT102  MON 15985  MON 88913.
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Fig. 1. Exposure of cotton bollworm (Helicoverpa zea) to conventional cotton leaf tissue
incorporated into an artiﬁcial diet at 1.5 mg/mL diet resulted in approximately 20%
growth inhibition (p < 0.05 denoted with an asterisk) over the 7-day bioassay period
compared to a negative control which was diet only and contained no leaf tissue.
Survival over the duration of the assay was >95% in the negative control (diet only) and
conventional leaf tissue treatments.
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response curve (Newman, 2013). A shared parameter for control
weight was used in a combined analysis across all treatments from
the three replicate assays since treatments shared the control
treatments. In addition, a shared slope parameter was used in the
combined analysis since there was no signiﬁcant difference in
slopes across the treatments (p > 0.050), which is consistent with
substances that have the same mode of action (Casarett et al.,
2003). The assessment for additivity used the concentration addi-
tion model and followed the approach described by Tabashnik
(1992) and Jonker et al. (2011).
The model is represented by:
1/predicted EC50 ¼ pa/EC50aþpb/EC50b
where pa and pb are the proportions of the two single trait prod-
ucts, a ¼ COT102 and b ¼ MON 15895 in the stacked products
COT102  MON 15985 and COT102  MON 15985  MON 88913.
For both COT102 MON 15985 MON 88913 and COT102 MON
15985 pa and pb are equal to one because they are expressed 100%
in the stacked product. Following this approach, antagonism (less
than additivity) is concluded if the upper bound of the 95% CI for
the observed median effect level is less than the predicted median
effect level using the concentration addition model. Synergism
(greater than additivity) is concluded if the lower bound of the 95%
CI for the observed median effect level is greater than the predicted
median effect level using the concentration addition model. Addi-
tivity is concluded if the predicted median effect level is captured
within the 95% CI of the observed median effect level (Tabashnik,
1992; Jonker et al., 2011).
3. Results and discussion
The potential for interaction between PIPs can be assessed with
diet that has been amended with either ﬁnely ground plant ma-
terial producing the PIPs, puriﬁed material derived from plant tis-
sue, or material that was produced in a heterologous or cell free
expression system. Puriﬁed material or plant tissue can be com-
bined in an artiﬁcial diet to reﬂect a representative PIP ratio that is
expressed in planta or another ratio. Studies with either material
are acceptable to assess the potential for protein interaction (U.S.
EPA, 2009a; EFSA, 2010). However, if plant tissue is added to the
artiﬁcial diet, it can be used to address both interaction and efﬁcacy
of the product provided that expression is comparable between the
individual and combined trait products (Greenplate et al., 2003). As
previously discussed in the Introduction, the stacked product
COT102  MON 15985  MON 88913 and the single products
COT102 and MON 15985 have comparable Cry1Ac, Cry2Ab2 and
Vip3Aa expression levels across tissue types as determined by
enzyme-linked immunosorbent assay (ELISA) and growth stages in
representative tissues allowing for the results to be expressed on a
mg/mL tissue (Supplementary Table 1; OGTR, 2014).
For concentration response analyses of the stacks, the total
amount of tissue in diet in all treatments was made to be equal to
control for a small but signiﬁcant cotton tissue effect on CBW
growth. Over the duration of the 7-day bioassay, CBW growth in
control treatments was inhibited by approximately 20%; however,
mortality in both treatments was less than 5% (Fig. 1). Cotton pro-
duces gossypol as a natural defense chemical to protect against
insect feeding damage (Anilkumar et al., 2009). Previously, it was
shown that the combination of Cry1Ac and gossypol toxicity from
cotton leaf tissue is additive against CBW (Anilkumar et al., 2009).
Greenplate et al. (2003) also showed that Cry1Ac and Cry2Ab2 in
cotton are additive against Heliothis virescens, Helicoverpa zea, and
Spodoptera frugiperda. This additive relationship with gossypol waspresumed to also be the case for Vip3A.
CBWgrowth inhibition demonstrated concentration-dependent
responses after 7-days of feeding on leaf tissue derived from
COT102, MON 15985, COT102  MON 15985 and COT102  MON
15985  MON 88913 that was incorporated into an artiﬁcial diet.
Mortality in the control and treatment groups was low with no
single replicate exceeding 13% and 7%, respectively, and averaged
3% across all control and treatment replicates. EC50 values for
COT102 and MON 15985 were 0.86 mg tissue/mL diet (95% CI of
0.51e1.2 mg tissue/mL diet) and 0.082 mg tissue/mL diet (95% CI of
0.048e0.12 mg tissue/mL diet), respectively, indicating about a 10-
fold difference in CBW growth inhibition in a 7-day assay (Table 2,
Fig. 2). The estimated EC50 values for COT102  MON 15985 and
COT102  MON 15985  MON 88913 from diet bioassays were
comparable with values of 0.072 mg tissue/mL diet (95% CI
0.044e0.10 mg tissue/mL diet) and 0.077 mg tissue/mL diet (95% CI
0.046e0.11 mg tissue/mL diet), respectively (Table 2). Comparable
values for COT102MON15985 and COT102MON15985MON
88913 were expected because MON 88913 does not confer insect
protection.
An assessment of additivity for COT102 and MON 15985 in the
stacked products was evaluated with the concentration addition
model. The predicted EC50 value for the combined toxicity of
COT102 and MON 15985 is 0.075 mg tissue/mL diet and is captured
well within the 95% CI for the estimated EC50 values for
COT102  MON 15985 (0.044e0.10 mg tissue/mL diet) as well as
the estimated EC50 value for COT102  MON 15985  MON 88913
(0.046e0.11 mg tissue/mL diet) (Table 2). In addition, the predicted
and observed EC50 values for the stacked products deviate by  4%
(Table 2). This result is indicative of additivity and no interaction
between the insecticidal proteins produced by COT102 and MON
15985. Since the mechanistic similarity of mixture components is
not strictly correlated conceptually or empirically with a particular
model of additivity (Berenbaum, 1989), the conclusion of inde-
pendent action is made on the basis of several reports that Bt
proteins from different families (e.g., Cry1, Cry2, Vip3) do not share
binding sites. Luo et al. (2007) showed in reciprocal binding tests
with brush border membrane vesicles (BBMV) from Helicoverpa
armigera that Cry2Ab could not displace Cry1Ac. Hernandez-
Rodriguez et al. (2008) also used competitive binding assays with
BBMVs from two Heliothine species to show that Cry2Ab did not
compete for binding sites with the Cry1Ac protein. In contrast,
Table 2
Estimated 7-day Cotton bollworm (Helicoverpa zea) EC50 values and 95% conﬁdence intervals (CI) for COT102, MON 15985 COT102  MON 15985, COT102  MON
15985MON 88913 and predicted EC50 value for COT102MON 15985. A shared control weight at concentration equals zero (109mg) and a shared slope parameter of (0.92)
was used for joint concentration response modeling.
Treatment EC50 value (mg tissue/mL
diet)
95% CI Predicted EC50 value (mg tissue/mL
diet)
% deviation between predicted and observed EC50
values
COT102 0.86 0.51e1.2 NAa NA
MON 15985 0.082 0.048
e0.12
NA NA
COT102  MON 15985 0.072 0.044
e0.10
0.075b 4%
COT102  MON 15985  MON
88913
0.077 0.046
e0.11
0.075 3%
a NA ¼ not available for single products because prediction requires adding the toxicity of two endpoints.
b The standard error for the predicted EC50 value was estimated to 0.15 mg tissue/mL diet.
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Fig. 2. Concentration-responses for cotton bollworm (CBW, Helicoverpa zea) growth
inhibition over 7 days in artiﬁcial diet incorporation bioassays with leaf tissue derived
from (A) COT102, (B)MON 15985 and (C) COT102  MON 15985 and COT102  MON
15985  MON 88913. Concentration responses for COT102  MON 15985 and
COT102  MON 15985  MON 88913 were comparable. Combined activity, measured
as EC50 values, for COT102 and MON 15985 were consistent with predicted EC50 values
using the concentration addition model.
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Cry1Ac and Cry2Ab for growth and mortality responses of Heli-
coverpa armigera and Earias insulana neonate larvae. A factor of 0.9
up to 3-fold the predicted LC50 for mortality was reported and 0.67
up to 1.4 the EC50 for growth for Cry1Ac and Cry2Ab mixtures. Vip
proteins do not exhibit any structural similarity with the Cry toxins
and bind to different receptors in the insect midgut (Lee et al.,
2006; Sena et al., 2009). Competition binding assays and ligand
blotting assays with BBMVs from two Heliothine cotton pests
demonstrated that Vip3Aa does not inhibit the binding of either
Cry1Ac or Cry2Ab2 and vice-versa (Lee et al., 2006). Overall, these
studies support the conclusion that Cry1Ac, Cry2Ab and Vip3Aa act
independently.
Assessing the potential impact of a synergy on an environmental
risk assessment is a topic that has received attention in the litera-
ture. Belden et al. (2007) and Cedergreen (2014) proposed that a
biologically signiﬁcant and reproducible synergy represents more
than two-fold increase activity. However, detecting a synergy is not
the end of an assessment but rather the beginning and datamust be
evaluated with aweight of evidence approach. In 2009, a FIFRA SAP
(Federal Insecticide, Fungicide and Rodenticide Act Scientiﬁc
Advisory Panel) recommended to EPA that for combinations of PIPs
that have been previously registered as individual events, and have
a proven safety record, that a <10-fold synergy will not trigger
additional NTO testing (U.S. EPA, 2009a,b,c). The rationale for this
recommendation largely reﬂects the Tier 1 requirement to achieve
a margin of exposure of 10-times the expected environmental
concentration, which is the margin of exposure generally required
for Tier I NTO testing and assessments (U.S. EPA, 2007; U.S. EPA,
2010). This recommendation by the SAP provides a quantitative
science-based approach to address greater than additive effects
within the context of an environmental risk assessment.
Environmental risk assessments for cultivation of crops pro-
ducing Cry1Ac, Cry2Ab2 and/or Vip3Aa have concluded that it is
unlikely for there to be adverse effects to NTOs including threat-
ened and endangered species (U.S. EPA, 2002; U.S. EPA, 2005; U.S.
EPA, 2010; U.S. EPA, 2008; Raybould and Vlachos, 2011; CERA,
2015). These existing NTO assessments are consistent with com-
munity level ﬁeld NTO studies for Bollgard II, COT102 and Bollgard
III. Whitehouse et al. (2005) found only a subtle shift in the
arthropod community between Bollgard II and conventional cotton
that probably resulted from the reduction in Helicoverpa and other
lepidopteran species. Similarly, Whitehouse et al. (2007) found that
a transgenic cotton producing Vip3Aa appeared to have little effect
on the arthropod community other than on Helicoverpa. In a follow
on study with the stacked product, there was no overall signiﬁcant
difference between Bollgard II and Bollgard III invertebrate com-
munities after stacking COT102 with Bollgard II (Whitehouse et al.,
2014). The Australian ﬁeld study conducted by Whitehouse et al.
S.L. Levine et al. / Regulatory Toxicology and Pharmacology 79 (2016) 35e4140was largely consistent with results from U.S. ﬁeld studies (OGTR,
2014). In individual qualitative site assessments of arthropod
damage in Australia, no differences were observed between
COT102  MON 15985 and the conventional control for all com-
parisons for arthropod stressors that included aphids, boll weevils,
ﬂeahoppers, grasshoppers, plant bugs, spider mites, stink bugs,
thrips, and white ﬂies.
In addition to molecular and expression bridging studies
required by EPA, the authorities in Australia also required pheno-
typic and agronomic characterization for the environmental
assessment of COT102  MON 15985 and COT102  MON
15985 MON 88913. The two stacks were evaluated by comparing
to a conventional cotton variety with a similar genetic background
as well as MON 15985 MON 88913, MON 88913 and MON 15985
grown at six sites across cotton growing regions in Australia (OGTR,
2014). A range of characteristics were measured as indicators of
growth, development, agronomic performance and ﬁber quality to
assess the potential effect of the added vip3Aa gene. These included
early stand count at 21 days after planting, ﬁnal stand count, plant
vigor at 21 days after planting, plant height and nodes every 21 days
until harvest, nodes above white ﬂower, seed weight, seed index,
total seed per boll and ﬁber quality data. The phenotypic study
showed no consistent differences between the COT102  MON
15985 and COT102  MON 15985  MON 88913 and the compar-
ators, indicating that the phenotype for the two stacks is compa-
rable with the parental lines (OGTR, 2014).
Additionally, as part of the food and feed assessment for the
stack registration in Australia, the compositional analysis of seed
from COT102  MON 15985 and COT102  MON 15985  MON
88913 was evaluated by comparing the stacks to a conventional
cotton variety with a similar genetic background as well as to
twelve unique conventional cotton varieties grown at eight sites
across cotton growing regions in the US (OGTR, 2014). Cottonseed
samples were analyzed for nutrients including calories, carbohy-
drates, moisture, protein, total fat, acid detergent ﬁber, neutral
detergent ﬁber, crude ﬁber, total dietary ﬁber, amino acids, fatty
acids (C8-C22), minerals (calcium, copper, iron, magnesium, man-
ganese, phosphorus, potassium, sodium and zinc) and vitamin E as
well as anti-nutrients including gossypol (free and total) and three
cyclopropenoid fatty acids. The compositional data analysis
demonstrated substantial equivalence between the stacks and the
conventional control. Small observed differences were concluded
to not be meaningful from a food or feed safety or nutritional
perspective (OGTR, 2014).4. Conclusions
This study has demonstrated that the combined activity of
COT102 and MON 15985 is additive in a sensitive insect bioassay,
which is inconsistent with synergism.When Bt proteins are present
at concentrations below their no effect levels for toxicity, concen-
tration addition may not hold for speciﬁc effects that occur via
independent targets (Borgert, 2007), as indicated by binding
studies demonstrating that Vip3Aa does not inhibit Cry1Ac or
Cry2Ab2 binding and vice-versa. In instances where there is inde-
pendent activity, it is generally understood that exposed organisms
are not susceptible to combined effects as long as the concentra-
tions of all substances in the mixture do not exceed their no effect
levels (Kortenkamp and Altenburger, 2012).Transparency document
Transparency document related to this article can be found
online at http://dx.doi.org/10.1016/j.yrtph.2016.05.003.Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.yrtph.2016.05.003.
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